98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14712598.2025.2501728 | DOI Listing |
Front Immunol
September 2025
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Introduction: Cutaneous manifestations in adult-onset immunodeficiency (AOID) resulting from anti-interferon-gamma autoantibody (AIGA) are prevalent and can be classified into infective and reactive disorders. To date, no clinical studies have specifically examined pustular reaction in patients with AOID. This study aimed to provide an original characterization of the clinical manifestations associated with pustular reaction in AOID and to compare these features with those observed in a clinically similar entity, generalized pustular psoriasis (GPP).
View Article and Find Full Text PDFAnn Dermatol Venereol
September 2025
Department of Dermatology, René Dubos Hospital, Pontoise, France.
Background: Generalized pustular psoriasis (GPP) is a rare, severe, chronic neutrophilic skin disease involving the interleukin-36 (IL-36) pathway.
Objective: The main objective of the SCRIPTOR international non-interventional study was to describe sociodemographic and clinical characteristics of GPP. This paper focuses on data collected from participating French centers.
J Parasit Dis
September 2025
Department of Dermatology, Medical School of Oujda, Mohammed VI University Hospital of Oujda, Mohammed First University of Oujda, Oujda, Morocco.
This paper presents a case of a 43-year-old man with Down syndrome misdiagnosed with psoriasis, later diagnosed with CS. Clinical manifestations included pruritus, hyperkeratotic plaques, and yellow crusts on the scalp, hands, and feet. Laboratory findings revealed eosinophilia and confirmed scabies through mite identification.
View Article and Find Full Text PDFBr J Dermatol
September 2025
Department of Dermatology, Allergy, and Venerology, University of Lübeck, Lübeck, Germany.
Background: Psoriasis is associated with a significant comorbidity burden, especially cardiovascular and metabolic complications. Glucagon-like peptide-1 receptor agonists (GLP-1RA), such as semaglutide, used to treat obesity and diabetes, could potentially reduce comorbidity in patients with psoriasis.
Objective: To investigate all-cause mortality, cardiovascular, inflammatory, psychiatric outcomes, and adverse events in psoriasis patients treated with GLP-1RA.
Health Econ Rev
September 2025
Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Unlabelled: Generalized pustular psoriasis (GPP), as a rare type of life-threatening psoriasis with currently no effective treatment, imposes a huge economic burden on the healthcare systems. This systematic review aimed to summarize studies on the economic burden of GPP and the corresponding key cost drivers. A systematic search was conducted on PubMed, Web of Science, and Scopus for eligible studies published between 1st January 2000 and 31st December 2024.
View Article and Find Full Text PDF